Aim for 20-30g at each eating occasion
This case is relevant as, amidst emerging evidence of improved cardiovascular and obesity outcomes, it is anticipated that GLP1-RAs will be used more frequently in patients with and without kidney disease and may soon be added to the growing armamentarium of agents to slow the progression of diabetic kidney disease
Diabetes, Obesity and Metabolism , 19(9), 12001209
BHRC Paradise Valley offers the most comprehensive physician-prescribed peptide menu in the greater Phoenix metro
Patients with uncontrolled diabetes, active cancer, or significant cardiovascular disease typically require careful assessment before peptide initiation
Peer review Peer review information Nature Chemistry thanks the anonymous reviewers for their contribution to the peer review of this work